GO:0044391 | ribosomal subunit | 49.55% (111/224) | 5.62 | 0.0 | 0.0 |
GO:0003735 | structural constituent of ribosome | 49.55% (111/224) | 5.58 | 0.0 | 0.0 |
GO:0005198 | structural molecule activity | 50.0% (112/224) | 5.06 | 0.0 | 0.0 |
GO:1990904 | ribonucleoprotein complex | 57.14% (128/224) | 4.32 | 0.0 | 0.0 |
GO:0002181 | cytoplasmic translation | 37.95% (85/224) | 5.92 | 0.0 | 0.0 |
GO:0006412 | translation | 44.2% (99/224) | 5.22 | 0.0 | 0.0 |
GO:0043043 | peptide biosynthetic process | 44.2% (99/224) | 5.13 | 0.0 | 0.0 |
GO:0042788 | polysomal ribosome | 35.71% (80/224) | 5.91 | 0.0 | 0.0 |
GO:0034645 | cellular macromolecule biosynthetic process | 50.45% (113/224) | 4.38 | 0.0 | 0.0 |
GO:0043604 | amide biosynthetic process | 44.64% (100/224) | 4.72 | 0.0 | 0.0 |
GO:0006518 | peptide metabolic process | 45.09% (101/224) | 4.66 | 0.0 | 0.0 |
GO:0009059 | macromolecule biosynthetic process | 53.57% (120/224) | 3.77 | 0.0 | 0.0 |
GO:0005840 | ribosome | 37.5% (84/224) | 4.97 | 0.0 | 0.0 |
GO:0043603 | cellular amide metabolic process | 45.98% (103/224) | 4.1 | 0.0 | 0.0 |
GO:0003729 | mRNA binding | 52.68% (118/224) | 3.62 | 0.0 | 0.0 |
GO:0003723 | RNA binding | 58.48% (131/224) | 3.17 | 0.0 | 0.0 |
GO:0022625 | cytosolic large ribosomal subunit | 28.57% (64/224) | 5.78 | 0.0 | 0.0 |
GO:0015934 | large ribosomal subunit | 29.46% (66/224) | 5.57 | 0.0 | 0.0 |
GO:0032991 | protein-containing complex | 69.64% (156/224) | 2.49 | 0.0 | 0.0 |
GO:0005730 | nucleolus | 45.98% (103/224) | 3.72 | 0.0 | 0.0 |
GO:0044271 | cellular nitrogen compound biosynthetic process | 49.55% (111/224) | 3.32 | 0.0 | 0.0 |
GO:0043228 | non-membrane-bounded organelle | 59.82% (134/224) | 2.76 | 0.0 | 0.0 |
GO:0043232 | intracellular non-membrane-bounded organelle | 59.82% (134/224) | 2.76 | 0.0 | 0.0 |
GO:0044260 | cellular macromolecule metabolic process | 56.25% (126/224) | 2.68 | 0.0 | 0.0 |
GO:0022627 | cytosolic small ribosomal subunit | 21.43% (48/224) | 5.9 | 0.0 | 0.0 |
GO:0015935 | small ribosomal subunit | 21.88% (49/224) | 5.71 | 0.0 | 0.0 |
GO:0003676 | nucleic acid binding | 66.52% (149/224) | 2.19 | 0.0 | 0.0 |
GO:1901566 | organonitrogen compound biosynthetic process | 47.32% (106/224) | 3.03 | 0.0 | 0.0 |
GO:0034641 | cellular nitrogen compound metabolic process | 62.05% (139/224) | 2.19 | 0.0 | 0.0 |
GO:0019843 | rRNA binding | 20.54% (46/224) | 5.04 | 0.0 | 0.0 |
GO:0006364 | rRNA processing | 23.21% (52/224) | 4.45 | 0.0 | 0.0 |
GO:0043170 | macromolecule metabolic process | 70.09% (157/224) | 1.65 | 0.0 | 0.0 |
GO:0044249 | cellular biosynthetic process | 57.59% (129/224) | 2.04 | 0.0 | 0.0 |
GO:0016072 | rRNA metabolic process | 23.21% (52/224) | 4.31 | 0.0 | 0.0 |
GO:1901576 | organic substance biosynthetic process | 58.04% (130/224) | 1.96 | 0.0 | 0.0 |
GO:0009058 | biosynthetic process | 58.04% (130/224) | 1.89 | 0.0 | 0.0 |
GO:1901363 | heterocyclic compound binding | 70.09% (157/224) | 1.5 | 0.0 | 0.0 |
GO:0097159 | organic cyclic compound binding | 70.09% (157/224) | 1.49 | 0.0 | 0.0 |
GO:0034470 | ncRNA processing | 25.45% (57/224) | 3.5 | 0.0 | 0.0 |
GO:0034660 | ncRNA metabolic process | 27.23% (61/224) | 3.32 | 0.0 | 0.0 |
GO:0098556 | cytoplasmic side of rough endoplasmic reticulum membrane | 12.5% (28/224) | 5.83 | 0.0 | 0.0 |
GO:0045202 | synapse | 20.98% (47/224) | 3.96 | 0.0 | 0.0 |
GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane | 12.5% (28/224) | 5.8 | 0.0 | 0.0 |
GO:0019538 | protein metabolic process | 50.45% (113/224) | 1.91 | 0.0 | 0.0 |
GO:0030054 | cell junction | 41.52% (93/224) | 2.16 | 0.0 | 0.0 |
GO:0006807 | nitrogen compound metabolic process | 67.86% (152/224) | 1.28 | 0.0 | 0.0 |
GO:0022618 | ribonucleoprotein complex assembly | 16.07% (36/224) | 4.23 | 0.0 | 0.0 |
GO:0016070 | RNA metabolic process | 32.59% (73/224) | 2.45 | 0.0 | 0.0 |
GO:0071826 | ribonucleoprotein complex subunit organization | 16.07% (36/224) | 4.15 | 0.0 | 0.0 |
GO:0044237 | cellular metabolic process | 73.21% (164/224) | 1.11 | 0.0 | 0.0 |
GO:0098562 | cytoplasmic side of membrane | 12.5% (28/224) | 4.92 | 0.0 | 0.0 |
GO:0006396 | RNA processing | 27.23% (61/224) | 2.66 | 0.0 | 0.0 |
GO:0044238 | primary metabolic process | 68.75% (154/224) | 1.11 | 0.0 | 0.0 |
GO:0000028 | ribosomal small subunit assembly | 7.59% (17/224) | 6.36 | 0.0 | 0.0 |
GO:0071704 | organic substance metabolic process | 73.21% (164/224) | 0.98 | 0.0 | 0.0 |
GO:0008152 | metabolic process | 75.89% (170/224) | 0.93 | 0.0 | 0.0 |
GO:0098552 | side of membrane | 12.95% (29/224) | 4.19 | 0.0 | 0.0 |
GO:0014069 | postsynaptic density | 11.16% (25/224) | 4.63 | 0.0 | 0.0 |
GO:0099572 | postsynaptic specialization | 11.16% (25/224) | 4.63 | 0.0 | 0.0 |
GO:0090304 | nucleic acid metabolic process | 33.48% (75/224) | 2.02 | 0.0 | 0.0 |
GO:1901564 | organonitrogen compound metabolic process | 54.46% (122/224) | 1.32 | 0.0 | 0.0 |
GO:0045182 | translation regulator activity | 12.5% (28/224) | 4.12 | 0.0 | 0.0 |
GO:0009506 | plasmodesma | 32.14% (72/224) | 2.04 | 0.0 | 0.0 |
GO:0009987 | cellular process | 85.27% (191/224) | 0.71 | 0.0 | 0.0 |
GO:0005911 | cell-cell junction | 32.14% (72/224) | 2.01 | 0.0 | 0.0 |
GO:0070161 | anchoring junction | 32.14% (72/224) | 1.99 | 0.0 | 0.0 |
GO:0005488 | binding | 83.04% (186/224) | 0.73 | 0.0 | 0.0 |
GO:0030490 | maturation of SSU-rRNA | 8.93% (20/224) | 5.05 | 0.0 | 0.0 |
GO:0010608 | post-transcriptional regulation of gene expression | 17.41% (39/224) | 3.04 | 0.0 | 0.0 |
GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 8.48% (19/224) | 5.13 | 0.0 | 0.0 |
GO:0006139 | nucleobase-containing compound metabolic process | 34.82% (78/224) | 1.79 | 0.0 | 0.0 |
GO:0030684 | preribosome | 9.38% (21/224) | 4.62 | 0.0 | 0.0 |
GO:0043229 | intracellular organelle | 72.32% (162/224) | 0.86 | 0.0 | 0.0 |
GO:0005774 | vacuolar membrane | 24.11% (54/224) | 2.29 | 0.0 | 0.0 |
GO:0043226 | organelle | 72.32% (162/224) | 0.85 | 0.0 | 0.0 |
GO:0006417 | regulation of translation | 14.73% (33/224) | 3.2 | 0.0 | 0.0 |
GO:0065003 | protein-containing complex assembly | 20.09% (45/224) | 2.53 | 0.0 | 0.0 |
GO:0034248 | regulation of cellular amide metabolic process | 14.73% (33/224) | 3.1 | 0.0 | 0.0 |
GO:0008150 | biological_process | 89.29% (200/224) | 0.54 | 0.0 | 0.0 |
GO:0043933 | protein-containing complex organization | 20.54% (46/224) | 2.36 | 0.0 | 0.0 |
GO:0005575 | cellular_component | 88.39% (198/224) | 0.53 | 0.0 | 0.0 |
GO:1990932 | 5.8S rRNA binding | 4.91% (11/224) | 6.45 | 0.0 | 0.0 |
GO:0005515 | protein binding | 67.41% (151/224) | 0.83 | 0.0 | 0.0 |
GO:2000112 | regulation of cellular macromolecule biosynthetic process | 14.73% (33/224) | 2.78 | 0.0 | 0.0 |
GO:0005654 | nucleoplasm | 20.54% (46/224) | 2.17 | 0.0 | 0.0 |
GO:0022607 | cellular component assembly | 24.11% (54/224) | 1.93 | 0.0 | 0.0 |
GO:0003674 | molecular_function | 85.71% (192/224) | 0.52 | 0.0 | 0.0 |
GO:0046483 | heterocycle metabolic process | 35.27% (79/224) | 1.42 | 0.0 | 0.0 |
GO:0008097 | 5S rRNA binding | 4.91% (11/224) | 5.86 | 0.0 | 0.0 |
GO:0045727 | positive regulation of translation | 8.48% (19/224) | 3.87 | 0.0 | 0.0 |
GO:0051246 | regulation of protein metabolic process | 21.88% (49/224) | 1.98 | 0.0 | 0.0 |
GO:0071840 | cellular component organization or biogenesis | 40.62% (91/224) | 1.22 | 0.0 | 0.0 |
GO:0055105 | ubiquitin-protein transferase inhibitor activity | 4.46% (10/224) | 6.01 | 0.0 | 0.0 |
GO:1990948 | ubiquitin ligase inhibitor activity | 4.46% (10/224) | 6.01 | 0.0 | 0.0 |
GO:0010628 | positive regulation of gene expression | 14.29% (32/224) | 2.6 | 0.0 | 0.0 |
GO:0097421 | liver regeneration | 5.36% (12/224) | 5.22 | 0.0 | 0.0 |
GO:0110165 | cellular anatomical entity | 84.82% (190/224) | 0.5 | 0.0 | 0.0 |
GO:0034250 | positive regulation of cellular amide metabolic process | 8.48% (19/224) | 3.68 | 0.0 | 0.0 |
GO:0000469 | cleavage involved in rRNA processing | 6.25% (14/224) | 4.54 | 0.0 | 0.0 |
GO:0006414 | translational elongation | 5.8% (13/224) | 4.76 | 0.0 | 0.0 |
GO:0090079 | translation regulator activity, nucleic acid binding | 7.59% (17/224) | 3.87 | 0.0 | 0.0 |
GO:0000228 | nuclear chromosome | 6.7% (15/224) | 4.18 | 0.0 | 0.0 |
GO:0000027 | ribosomal large subunit assembly | 4.91% (11/224) | 5.21 | 0.0 | 0.0 |
GO:0098588 | bounding membrane of organelle | 24.55% (55/224) | 1.65 | 0.0 | 0.0 |
GO:0006725 | cellular aromatic compound metabolic process | 35.71% (80/224) | 1.24 | 0.0 | 0.0 |
GO:0051444 | negative regulation of ubiquitin-protein transferase activity | 4.02% (9/224) | 5.86 | 0.0 | 0.0 |
GO:1904667 | negative regulation of ubiquitin protein ligase activity | 4.02% (9/224) | 5.86 | 0.0 | 0.0 |
GO:0008135 | translation factor activity, RNA binding | 6.7% (15/224) | 4.05 | 0.0 | 0.0 |
GO:1901798 | positive regulation of signal transduction by p53 class mediator | 4.46% (10/224) | 5.41 | 0.0 | 0.0 |
GO:0022613 | ribonucleoprotein complex biogenesis | 6.7% (15/224) | 4.01 | 0.0 | 0.0 |
GO:0031100 | animal organ regeneration | 5.36% (12/224) | 4.71 | 0.0 | 0.0 |
GO:0055106 | ubiquitin-protein transferase regulator activity | 4.46% (10/224) | 5.34 | 0.0 | 0.0 |
GO:0051438 | regulation of ubiquitin-protein transferase activity | 4.91% (11/224) | 4.95 | 0.0 | 0.0 |
GO:0045471 | response to ethanol | 5.8% (13/224) | 4.37 | 0.0 | 0.0 |
GO:0000470 | maturation of LSU-rRNA | 4.91% (11/224) | 4.91 | 0.0 | 0.0 |
GO:0032040 | small-subunit processome | 4.46% (10/224) | 5.1 | 0.0 | 0.0 |
GO:0005886 | plasma membrane | 32.14% (72/224) | 1.23 | 0.0 | 0.0 |
GO:1901796 | regulation of signal transduction by p53 class mediator | 5.36% (12/224) | 4.33 | 0.0 | 0.0 |
GO:0045903 | positive regulation of translational fidelity | 3.12% (7/224) | 6.35 | 0.0 | 0.0 |
GO:0000479 | endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 4.91% (11/224) | 4.57 | 0.0 | 0.0 |
GO:0051348 | negative regulation of transferase activity | 5.8% (13/224) | 4.05 | 0.0 | 0.0 |
GO:0048513 | animal organ development | 13.39% (30/224) | 2.24 | 0.0 | 0.0 |
GO:1901360 | organic cyclic compound metabolic process | 35.71% (80/224) | 1.11 | 0.0 | 0.0 |
GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator | 2.68% (6/224) | 6.86 | 0.0 | 0.0 |
GO:0000478 | endonucleolytic cleavage involved in rRNA processing | 4.91% (11/224) | 4.48 | 0.0 | 0.0 |
GO:1903321 | negative regulation of protein modification by small protein conjugation or removal | 4.91% (11/224) | 4.46 | 0.0 | 0.0 |
GO:0006413 | translational initiation | 4.46% (10/224) | 4.72 | 0.0 | 0.0 |
GO:0031672 | A band | 3.57% (8/224) | 5.54 | 0.0 | 0.0 |
GO:0005618 | cell wall | 16.96% (38/224) | 1.86 | 0.0 | 0.0 |
GO:0051338 | regulation of transferase activity | 8.93% (20/224) | 2.87 | 0.0 | 0.0 |
GO:1904666 | regulation of ubiquitin protein ligase activity | 4.02% (9/224) | 5.06 | 0.0 | 0.0 |
GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic | 5.36% (12/224) | 4.04 | 0.0 | 0.0 |
GO:0010468 | regulation of gene expression | 29.91% (67/224) | 1.22 | 0.0 | 0.0 |
GO:0006450 | regulation of translational fidelity | 3.57% (8/224) | 5.4 | 0.0 | 0.0 |
GO:0001889 | liver development | 5.36% (12/224) | 3.99 | 0.0 | 0.0 |
GO:0031397 | negative regulation of protein ubiquitination | 4.46% (10/224) | 4.52 | 0.0 | 0.0 |
GO:2000059 | negative regulation of ubiquitin-dependent protein catabolic process | 4.46% (10/224) | 4.5 | 0.0 | 0.0 |
GO:0030312 | external encapsulating structure | 16.96% (38/224) | 1.78 | 0.0 | 0.0 |
GO:0030687 | preribosome, large subunit precursor | 4.02% (9/224) | 4.78 | 0.0 | 0.0 |
GO:0031099 | regeneration | 5.8% (13/224) | 3.66 | 0.0 | 0.0 |
GO:1903051 | negative regulation of proteolysis involved in protein catabolic process | 4.46% (10/224) | 4.34 | 0.0 | 0.0 |
GO:0003746 | translation elongation factor activity | 3.57% (8/224) | 5.05 | 0.0 | 0.0 |
GO:2001244 | positive regulation of intrinsic apoptotic signaling pathway | 3.12% (7/224) | 5.55 | 0.0 | 0.0 |
GO:0031090 | organelle membrane | 29.02% (65/224) | 1.18 | 0.0 | 0.0 |
GO:0090501 | RNA phosphodiester bond hydrolysis | 6.25% (14/224) | 3.37 | 0.0 | 0.0 |
GO:0060255 | regulation of macromolecule metabolic process | 33.04% (74/224) | 1.06 | 0.0 | 0.0 |
GO:0048027 | mRNA 5'-UTR binding | 4.02% (9/224) | 4.59 | 0.0 | 0.0 |
GO:0071310 | cellular response to organic substance | 14.73% (33/224) | 1.86 | 0.0 | 0.0 |
GO:1903320 | regulation of protein modification by small protein conjugation or removal | 6.25% (14/224) | 3.32 | 0.0 | 0.0 |
GO:0070181 | small ribosomal subunit rRNA binding | 3.12% (7/224) | 5.45 | 0.0 | 0.0 |
GO:0048732 | gland development | 5.8% (13/224) | 3.49 | 0.0 | 0.0 |
GO:0016043 | cellular component organization | 33.48% (75/224) | 1.04 | 0.0 | 0.0 |
GO:0002182 | cytoplasmic translational elongation | 2.68% (6/224) | 6.03 | 0.0 | 0.0 |
GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 3.12% (7/224) | 5.4 | 0.0 | 0.0 |
GO:0031396 | regulation of protein ubiquitination | 5.8% (13/224) | 3.44 | 0.0 | 0.0 |
GO:1902253 | regulation of intrinsic apoptotic signaling pathway by p53 class mediator | 3.12% (7/224) | 5.3 | 0.0 | 0.0 |
GO:0050790 | regulation of catalytic activity | 12.95% (29/224) | 1.97 | 0.0 | 0.0 |
GO:0043065 | positive regulation of apoptotic process | 5.8% (13/224) | 3.38 | 0.0 | 0.0 |
GO:0008284 | positive regulation of cell population proliferation | 8.04% (18/224) | 2.68 | 0.0 | 0.0 |
GO:0097014 | ciliary plasm | 2.23% (5/224) | 6.6 | 0.0 | 0.0 |
GO:0043021 | ribonucleoprotein complex binding | 5.8% (13/224) | 3.3 | 0.0 | 0.0 |
GO:0080090 | regulation of primary metabolic process | 31.7% (71/224) | 1.03 | 0.0 | 0.0 |
GO:0051171 | regulation of nitrogen compound metabolic process | 30.36% (68/224) | 1.06 | 0.0 | 0.0 |
GO:0010605 | negative regulation of macromolecule metabolic process | 19.64% (44/224) | 1.43 | 0.0 | 0.0 |
GO:2001235 | positive regulation of apoptotic signaling pathway | 3.12% (7/224) | 5.01 | 0.0 | 0.0 |
GO:0016020 | membrane | 46.88% (105/224) | 0.73 | 0.0 | 0.0 |
GO:0019222 | regulation of metabolic process | 36.16% (81/224) | 0.91 | 0.0 | 0.0 |
GO:0034097 | response to cytokine | 6.7% (15/224) | 2.91 | 0.0 | 0.0 |
GO:0031330 | negative regulation of cellular catabolic process | 5.8% (13/224) | 3.21 | 0.0 | 0.0 |
GO:0009892 | negative regulation of metabolic process | 20.54% (46/224) | 1.35 | 0.0 | 0.0 |
GO:0071345 | cellular response to cytokine stimulus | 5.8% (13/224) | 3.07 | 0.0 | 0.0 |
GO:0071320 | cellular response to cAMP | 2.68% (6/224) | 5.17 | 0.0 | 0.0 |
GO:0050794 | regulation of cellular process | 46.88% (105/224) | 0.68 | 0.0 | 0.0 |
GO:0090305 | nucleic acid phosphodiester bond hydrolysis | 6.25% (14/224) | 2.8 | 0.0 | 0.0 |
GO:0065007 | biological regulation | 54.91% (123/224) | 0.58 | 0.0 | 0.0 |
GO:0031323 | regulation of cellular metabolic process | 31.25% (70/224) | 0.94 | 0.0 | 0.0 |
GO:1904400 | response to Thyroid stimulating hormone | 2.23% (5/224) | 5.77 | 0.0 | 0.0 |
GO:1904401 | cellular response to Thyroid stimulating hormone | 2.23% (5/224) | 5.77 | 0.0 | 0.0 |
GO:1904587 | response to glycoprotein | 2.23% (5/224) | 5.77 | 0.0 | 0.0 |
GO:1904588 | cellular response to glycoprotein | 2.23% (5/224) | 5.77 | 0.0 | 0.0 |
GO:0051172 | negative regulation of nitrogen compound metabolic process | 16.52% (37/224) | 1.45 | 0.0 | 0.0 |
GO:0050789 | regulation of biological process | 51.34% (115/224) | 0.61 | 0.0 | 0.0 |
GO:0051248 | negative regulation of protein metabolic process | 9.38% (21/224) | 2.08 | 0.0 | 0.0 |
GO:0005694 | chromosome | 7.59% (17/224) | 2.38 | 0.0 | 1e-06 |
GO:0070180 | large ribosomal subunit rRNA binding | 2.68% (6/224) | 4.9 | 0.0 | 1e-06 |
GO:0030234 | enzyme regulator activity | 9.38% (21/224) | 2.04 | 0.0 | 1e-06 |
GO:0009895 | negative regulation of catabolic process | 5.8% (13/224) | 2.79 | 0.0 | 1e-06 |
GO:0003743 | translation initiation factor activity | 3.57% (8/224) | 3.85 | 0.0 | 1e-06 |
GO:0010556 | regulation of macromolecule biosynthetic process | 22.77% (51/224) | 1.09 | 0.0 | 2e-06 |
GO:2000435 | negative regulation of protein neddylation | 1.79% (4/224) | 6.28 | 0.0 | 2e-06 |
GO:0031324 | negative regulation of cellular metabolic process | 15.62% (35/224) | 1.39 | 0.0 | 2e-06 |
GO:0042254 | ribosome biogenesis | 3.57% (8/224) | 3.73 | 0.0 | 2e-06 |
GO:0005853 | eukaryotic translation elongation factor 1 complex | 1.34% (3/224) | 7.45 | 0.0 | 2e-06 |
GO:0017134 | fibroblast growth factor binding | 1.34% (3/224) | 7.45 | 0.0 | 2e-06 |
GO:0006924 | activation-induced cell death of T cells | 1.34% (3/224) | 7.45 | 0.0 | 2e-06 |
GO:1903347 | negative regulation of bicellular tight junction assembly | 1.34% (3/224) | 7.45 | 0.0 | 2e-06 |
GO:0045861 | negative regulation of proteolysis | 4.91% (11/224) | 2.97 | 0.0 | 3e-06 |
GO:1990145 | maintenance of translational fidelity | 1.79% (4/224) | 6.13 | 0.0 | 3e-06 |
GO:0006407 | rRNA export from nucleus | 1.79% (4/224) | 6.13 | 0.0 | 3e-06 |
GO:0032838 | plasma membrane bounded cell projection cytoplasm | 2.68% (6/224) | 4.54 | 0.0 | 3e-06 |
GO:0051247 | positive regulation of protein metabolic process | 9.82% (22/224) | 1.86 | 0.0 | 3e-06 |
GO:0042981 | regulation of apoptotic process | 8.04% (18/224) | 2.1 | 0.0 | 4e-06 |
GO:0098772 | molecular function regulator activity | 9.82% (22/224) | 1.84 | 0.0 | 4e-06 |
GO:2001242 | regulation of intrinsic apoptotic signaling pathway | 3.57% (8/224) | 3.63 | 0.0 | 4e-06 |
GO:0051029 | rRNA transport | 1.79% (4/224) | 5.99 | 0.0 | 4e-06 |
GO:2000434 | regulation of protein neddylation | 1.79% (4/224) | 5.86 | 1e-06 | 6e-06 |
GO:0042127 | regulation of cell population proliferation | 8.93% (20/224) | 1.9 | 1e-06 | 7e-06 |
GO:0065009 | regulation of molecular function | 13.84% (31/224) | 1.42 | 1e-06 | 8e-06 |
GO:1901193 | regulation of formation of translation preinitiation complex | 1.34% (3/224) | 7.03 | 1e-06 | 9e-06 |
GO:1901194 | negative regulation of formation of translation preinitiation complex | 1.34% (3/224) | 7.03 | 1e-06 | 9e-06 |
GO:1904689 | negative regulation of cytoplasmic translational initiation | 1.34% (3/224) | 7.03 | 1e-06 | 9e-06 |
GO:0031326 | regulation of cellular biosynthetic process | 24.11% (54/224) | 0.96 | 1e-06 | 1.2e-05 |
GO:0009889 | regulation of biosynthetic process | 24.55% (55/224) | 0.94 | 1e-06 | 1.4e-05 |
GO:0097064 | ncRNA export from nucleus | 1.79% (4/224) | 5.54 | 1e-06 | 1.6e-05 |
GO:0050821 | protein stabilization | 4.46% (10/224) | 2.86 | 1e-06 | 1.7e-05 |
GO:0051726 | regulation of cell cycle | 9.38% (21/224) | 1.74 | 2e-06 | 2e-05 |
GO:0070227 | lymphocyte apoptotic process | 1.34% (3/224) | 6.71 | 2e-06 | 2.1e-05 |
GO:0070231 | T cell apoptotic process | 1.34% (3/224) | 6.71 | 2e-06 | 2.1e-05 |
GO:0071887 | leukocyte apoptotic process | 1.34% (3/224) | 6.71 | 2e-06 | 2.1e-05 |
GO:2000058 | regulation of ubiquitin-dependent protein catabolic process | 4.46% (10/224) | 2.8 | 2e-06 | 2.4e-05 |
GO:0044092 | negative regulation of molecular function | 7.59% (17/224) | 1.96 | 2e-06 | 2.7e-05 |
GO:0045947 | negative regulation of translational initiation | 1.79% (4/224) | 5.36 | 2e-06 | 2.7e-05 |
GO:1990089 | response to nerve growth factor | 2.68% (6/224) | 3.97 | 2e-06 | 2.8e-05 |
GO:1990090 | cellular response to nerve growth factor stimulus | 2.68% (6/224) | 3.97 | 2e-06 | 2.8e-05 |
GO:0009792 | embryo development ending in birth or egg hatching | 4.91% (11/224) | 2.6 | 2e-06 | 2.8e-05 |
GO:0044877 | protein-containing complex binding | 8.93% (20/224) | 1.75 | 3e-06 | 2.9e-05 |
GO:0043068 | positive regulation of programmed cell death | 5.8% (13/224) | 2.32 | 3e-06 | 2.9e-05 |
GO:0048522 | positive regulation of cellular process | 25.45% (57/224) | 0.88 | 3e-06 | 3e-05 |
GO:0042273 | ribosomal large subunit biogenesis | 2.23% (5/224) | 4.48 | 3e-06 | 3.2e-05 |
GO:0031400 | negative regulation of protein modification process | 5.36% (12/224) | 2.43 | 3e-06 | 3.3e-05 |
GO:0060425 | lung morphogenesis | 1.34% (3/224) | 6.45 | 4e-06 | 3.9e-05 |
GO:0002309 | T cell proliferation involved in immune response | 1.34% (3/224) | 6.45 | 4e-06 | 3.9e-05 |
GO:2000810 | regulation of bicellular tight junction assembly | 1.34% (3/224) | 6.45 | 4e-06 | 3.9e-05 |
GO:1900259 | regulation of RNA-directed 5'-3' RNA polymerase activity | 1.34% (3/224) | 6.45 | 4e-06 | 3.9e-05 |
GO:1900260 | negative regulation of RNA-directed 5'-3' RNA polymerase activity | 1.34% (3/224) | 6.45 | 4e-06 | 3.9e-05 |
GO:0019838 | growth factor binding | 1.79% (4/224) | 5.2 | 4e-06 | 4.1e-05 |
GO:0043086 | negative regulation of catalytic activity | 5.8% (13/224) | 2.27 | 4e-06 | 4.1e-05 |
GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 2.23% (5/224) | 4.34 | 5e-06 | 5e-05 |
GO:0031369 | translation initiation factor binding | 2.68% (6/224) | 3.8 | 5e-06 | 5.1e-05 |
GO:0000171 | ribonuclease MRP activity | 1.34% (3/224) | 6.22 | 6e-06 | 6.6e-05 |
GO:0048246 | macrophage chemotaxis | 1.34% (3/224) | 6.22 | 6e-06 | 6.6e-05 |
GO:1904688 | regulation of cytoplasmic translational initiation | 1.34% (3/224) | 6.22 | 6e-06 | 6.6e-05 |
GO:1905517 | macrophage migration | 1.34% (3/224) | 6.22 | 6e-06 | 6.6e-05 |
GO:0022605 | mammalian oogenesis stage | 1.34% (3/224) | 6.22 | 6e-06 | 6.6e-05 |
GO:0030162 | regulation of proteolysis | 6.25% (14/224) | 2.09 | 7e-06 | 6.9e-05 |
GO:0071495 | cellular response to endogenous stimulus | 8.48% (19/224) | 1.7 | 8e-06 | 7.8e-05 |
GO:0051591 | response to cAMP | 2.68% (6/224) | 3.67 | 8e-06 | 8.2e-05 |
GO:1902533 | positive regulation of intracellular signal transduction | 5.36% (12/224) | 2.26 | 1e-05 | 0.0001 |
GO:0071346 | cellular response to interferon-gamma | 1.79% (4/224) | 4.86 | 1e-05 | 0.000103 |
GO:0034715 | pICln-Sm protein complex | 1.34% (3/224) | 6.03 | 1e-05 | 0.000103 |
GO:2001233 | regulation of apoptotic signaling pathway | 3.57% (8/224) | 2.94 | 1.1e-05 | 0.000112 |
GO:0000418 | RNA polymerase IV complex | 1.79% (4/224) | 4.8 | 1.2e-05 | 0.000121 |
GO:0070887 | cellular response to chemical stimulus | 16.07% (36/224) | 1.1 | 1.3e-05 | 0.000126 |
GO:0099568 | cytoplasmic region | 2.68% (6/224) | 3.56 | 1.3e-05 | 0.000128 |
GO:0043484 | regulation of RNA splicing | 4.02% (9/224) | 2.67 | 1.4e-05 | 0.000136 |
GO:0004857 | enzyme inhibitor activity | 4.91% (11/224) | 2.34 | 1.4e-05 | 0.000137 |
GO:1903050 | regulation of proteolysis involved in protein catabolic process | 4.46% (10/224) | 2.49 | 1.4e-05 | 0.000138 |
GO:0044085 | cellular component biogenesis | 6.7% (15/224) | 1.9 | 1.4e-05 | 0.00014 |
GO:0140098 | catalytic activity, acting on RNA | 6.7% (15/224) | 1.9 | 1.5e-05 | 0.000142 |
GO:0032435 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process | 2.23% (5/224) | 4.01 | 1.5e-05 | 0.000144 |
GO:0097371 | MDM2/MDM4 family protein binding | 1.34% (3/224) | 5.86 | 1.5e-05 | 0.000145 |
GO:0097452 | GAIT complex | 1.34% (3/224) | 5.86 | 1.5e-05 | 0.000145 |
GO:0042975 | peroxisome proliferator activated receptor binding | 1.34% (3/224) | 5.86 | 1.5e-05 | 0.000145 |
GO:1901889 | negative regulation of cell junction assembly | 1.34% (3/224) | 5.86 | 1.5e-05 | 0.000145 |
GO:0010942 | positive regulation of cell death | 5.8% (13/224) | 2.08 | 1.6e-05 | 0.000148 |
GO:0006366 | transcription by RNA polymerase II | 2.23% (5/224) | 3.94 | 1.9e-05 | 0.000184 |
GO:0097529 | myeloid leukocyte migration | 1.79% (4/224) | 4.59 | 2.2e-05 | 0.00021 |
GO:0006405 | RNA export from nucleus | 2.68% (6/224) | 3.4 | 2.4e-05 | 0.000224 |
GO:0071363 | cellular response to growth factor stimulus | 3.12% (7/224) | 3.04 | 2.5e-05 | 0.000233 |
GO:0034341 | response to interferon-gamma | 1.79% (4/224) | 4.54 | 2.6e-05 | 0.000239 |
GO:0051168 | nuclear export | 3.12% (7/224) | 3.04 | 2.6e-05 | 0.000242 |
GO:0030595 | leukocyte chemotaxis | 1.79% (4/224) | 4.49 | 2.9e-05 | 0.000271 |
GO:0070848 | response to growth factor | 3.12% (7/224) | 3.0 | 3.1e-05 | 0.000284 |
GO:0043022 | ribosome binding | 2.68% (6/224) | 3.33 | 3.1e-05 | 0.000289 |
GO:1901799 | negative regulation of proteasomal protein catabolic process | 2.23% (5/224) | 3.79 | 3.2e-05 | 0.00029 |
GO:0005665 | RNA polymerase II, core complex | 1.79% (4/224) | 4.45 | 3.3e-05 | 0.000303 |
GO:0001731 | formation of translation preinitiation complex | 1.79% (4/224) | 4.45 | 3.3e-05 | 0.000303 |
GO:0010629 | negative regulation of gene expression | 7.59% (17/224) | 1.65 | 3.5e-05 | 0.000318 |
GO:0006383 | transcription by RNA polymerase III | 1.79% (4/224) | 4.4 | 3.8e-05 | 0.00034 |
GO:0045901 | positive regulation of translational elongation | 1.34% (3/224) | 5.45 | 3.9e-05 | 0.000351 |
GO:0002286 | T cell activation involved in immune response | 1.34% (3/224) | 5.45 | 3.9e-05 | 0.000351 |
GO:0071361 | cellular response to ethanol | 1.34% (3/224) | 5.45 | 3.9e-05 | 0.000351 |
GO:0000082 | G1/S transition of mitotic cell cycle | 2.23% (5/224) | 3.72 | 4e-05 | 0.000354 |
GO:0008340 | determination of adult lifespan | 3.12% (7/224) | 2.91 | 4.4e-05 | 0.000394 |
GO:0030097 | hemopoiesis | 2.68% (6/224) | 3.24 | 4.5e-05 | 0.000402 |
GO:0002262 | myeloid cell homeostasis | 1.34% (3/224) | 5.33 | 5.1e-05 | 0.000448 |
GO:0010604 | positive regulation of macromolecule metabolic process | 16.52% (37/224) | 0.98 | 5.3e-05 | 0.000467 |
GO:0044843 | cell cycle G1/S phase transition | 2.23% (5/224) | 3.62 | 5.7e-05 | 0.000495 |
GO:0000419 | RNA polymerase V complex | 1.79% (4/224) | 4.24 | 6e-05 | 0.000521 |
GO:0055029 | nuclear DNA-directed RNA polymerase complex | 2.23% (5/224) | 3.6 | 6.1e-05 | 0.000526 |
GO:0000172 | ribonuclease MRP complex | 1.34% (3/224) | 5.22 | 6.5e-05 | 0.000557 |
GO:0042098 | T cell proliferation | 1.34% (3/224) | 5.22 | 6.5e-05 | 0.000557 |
GO:0048518 | positive regulation of biological process | 27.68% (62/224) | 0.68 | 6.9e-05 | 0.000593 |
GO:0048523 | negative regulation of cellular process | 20.09% (45/224) | 0.84 | 7.3e-05 | 0.000628 |
GO:0050900 | leukocyte migration | 1.79% (4/224) | 4.16 | 7.4e-05 | 0.00063 |
GO:0043067 | regulation of programmed cell death | 8.04% (18/224) | 1.51 | 7.6e-05 | 0.000646 |
GO:0071353 | cellular response to interleukin-4 | 1.34% (3/224) | 5.13 | 8e-05 | 0.000672 |
GO:0034719 | SMN-Sm protein complex | 1.34% (3/224) | 5.13 | 8e-05 | 0.000672 |
GO:1990446 | U1 snRNP binding | 1.34% (3/224) | 5.13 | 8e-05 | 0.000672 |
GO:0042274 | ribosomal small subunit biogenesis | 1.34% (3/224) | 5.13 | 8e-05 | 0.000672 |
GO:0033077 | T cell differentiation in thymus | 1.34% (3/224) | 5.13 | 8e-05 | 0.000672 |
GO:0033119 | negative regulation of RNA splicing | 1.79% (4/224) | 4.13 | 8.2e-05 | 0.000678 |
GO:0060326 | cell chemotaxis | 1.79% (4/224) | 4.13 | 8.2e-05 | 0.000678 |
GO:0006913 | nucleocytoplasmic transport | 3.57% (8/224) | 2.53 | 8.2e-05 | 0.000681 |
GO:0031647 | regulation of protein stability | 4.46% (10/224) | 2.18 | 8.7e-05 | 0.000715 |
GO:0051169 | nuclear transport | 3.57% (8/224) | 2.52 | 8.7e-05 | 0.000716 |
GO:0006446 | regulation of translational initiation | 2.23% (5/224) | 3.48 | 8.9e-05 | 0.000729 |
GO:0005732 | sno(s)RNA-containing ribonucleoprotein complex | 1.79% (4/224) | 4.09 | 9e-05 | 0.000736 |
GO:0030688 | preribosome, small subunit precursor | 1.34% (3/224) | 5.03 | 9.8e-05 | 0.000795 |
GO:0001890 | placenta development | 1.34% (3/224) | 5.03 | 9.8e-05 | 0.000795 |
GO:0002183 | cytoplasmic translational initiation | 1.34% (3/224) | 5.03 | 9.8e-05 | 0.000795 |
GO:0042541 | hemoglobin biosynthetic process | 0.89% (2/224) | 6.86 | 9.8e-05 | 0.000797 |
GO:0009893 | positive regulation of metabolic process | 17.86% (40/224) | 0.89 | 0.000101 | 0.00081 |
GO:0071417 | cellular response to organonitrogen compound | 4.46% (10/224) | 2.14 | 0.000107 | 0.000857 |
GO:0050657 | nucleic acid transport | 3.12% (7/224) | 2.71 | 0.000109 | 0.000872 |
GO:0050658 | RNA transport | 3.12% (7/224) | 2.71 | 0.000109 | 0.000872 |
GO:0045934 | negative regulation of nucleobase-containing compound metabolic process | 9.82% (22/224) | 1.29 | 0.000113 | 0.000896 |
GO:0051236 | establishment of RNA localization | 3.12% (7/224) | 2.7 | 0.000113 | 0.000899 |
GO:0070670 | response to interleukin-4 | 1.34% (3/224) | 4.94 | 0.000119 | 0.000934 |
GO:0005687 | U4 snRNP | 1.34% (3/224) | 4.94 | 0.000119 | 0.000934 |
GO:0009955 | adaxial/abaxial pattern specification | 1.34% (3/224) | 4.94 | 0.000119 | 0.000934 |
GO:0030217 | T cell differentiation | 1.79% (4/224) | 3.96 | 0.00013 | 0.001011 |
GO:0030218 | erythrocyte differentiation | 1.79% (4/224) | 3.96 | 0.00013 | 0.001011 |
GO:0071480 | cellular response to gamma radiation | 1.79% (4/224) | 3.96 | 0.00013 | 0.001011 |
GO:0048599 | oocyte development | 1.34% (3/224) | 4.86 | 0.000142 | 0.001095 |
GO:0070990 | snRNP binding | 1.34% (3/224) | 4.86 | 0.000142 | 0.001095 |
GO:0002285 | lymphocyte activation involved in immune response | 1.34% (3/224) | 4.86 | 0.000142 | 0.001095 |
GO:0044772 | mitotic cell cycle phase transition | 2.68% (6/224) | 2.93 | 0.000146 | 0.001119 |
GO:0043009 | chordate embryonic development | 3.12% (7/224) | 2.64 | 0.000146 | 0.00112 |
GO:0019901 | protein kinase binding | 5.36% (12/224) | 1.85 | 0.000149 | 0.001135 |
GO:0034709 | methylosome | 1.34% (3/224) | 4.78 | 0.000168 | 0.00128 |
GO:0071013 | catalytic step 2 spliceosome | 2.68% (6/224) | 2.86 | 0.000191 | 0.001451 |
GO:0000408 | EKC/KEOPS complex | 0.89% (2/224) | 6.45 | 0.000195 | 0.00146 |
GO:0002949 | tRNA threonylcarbamoyladenosine modification | 0.89% (2/224) | 6.45 | 0.000195 | 0.00146 |
GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity | 0.89% (2/224) | 6.45 | 0.000195 | 0.00146 |
GO:0140694 | non-membrane-bounded organelle assembly | 4.02% (9/224) | 2.18 | 0.000193 | 0.001464 |
GO:0048519 | negative regulation of biological process | 24.55% (55/224) | 0.68 | 0.000213 | 0.001591 |
GO:0071407 | cellular response to organic cyclic compound | 4.02% (9/224) | 2.15 | 0.00022 | 0.001637 |
GO:0048534 | hematopoietic or lymphoid organ development | 2.68% (6/224) | 2.82 | 0.000222 | 0.001648 |
GO:0032943 | mononuclear cell proliferation | 1.34% (3/224) | 4.64 | 0.000229 | 0.001681 |
GO:0046651 | lymphocyte proliferation | 1.34% (3/224) | 4.64 | 0.000229 | 0.001681 |
GO:0070661 | leukocyte proliferation | 1.34% (3/224) | 4.64 | 0.000229 | 0.001681 |
GO:0010941 | regulation of cell death | 8.48% (19/224) | 1.33 | 0.000227 | 0.001683 |
GO:0000428 | DNA-directed RNA polymerase complex | 2.23% (5/224) | 3.18 | 0.000236 | 0.001732 |
GO:0051253 | negative regulation of RNA metabolic process | 8.93% (20/224) | 1.29 | 0.000242 | 0.001764 |
GO:0044770 | cell cycle phase transition | 2.68% (6/224) | 2.78 | 0.000256 | 0.001864 |
GO:0031399 | regulation of protein modification process | 7.59% (17/224) | 1.41 | 0.000259 | 0.001877 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 7.14% (16/224) | 1.46 | 0.000275 | 0.001988 |
GO:1902531 | regulation of intracellular signal transduction | 7.14% (16/224) | 1.46 | 0.000281 | 0.002026 |
GO:0034063 | stress granule assembly | 1.79% (4/224) | 3.67 | 0.000285 | 0.002049 |
GO:0016236 | macroautophagy | 2.23% (5/224) | 3.13 | 0.000286 | 0.002052 |
GO:0000460 | maturation of 5.8S rRNA | 1.34% (3/224) | 4.51 | 0.000302 | 0.002162 |
GO:0044093 | positive regulation of molecular function | 6.25% (14/224) | 1.57 | 0.000311 | 0.00222 |
GO:0020027 | hemoglobin metabolic process | 0.89% (2/224) | 6.13 | 0.000323 | 0.002294 |
GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage | 0.89% (2/224) | 6.13 | 0.000323 | 0.002294 |
GO:0046683 | response to organophosphorus | 2.68% (6/224) | 2.72 | 0.000326 | 0.002307 |
GO:0005666 | RNA polymerase III complex | 1.34% (3/224) | 4.45 | 0.000344 | 0.002426 |
GO:0030880 | RNA polymerase complex | 2.23% (5/224) | 3.05 | 0.000358 | 0.002522 |
GO:0005685 | U1 snRNP | 1.34% (3/224) | 4.39 | 0.000389 | 0.002715 |
GO:0048821 | erythrocyte development | 1.34% (3/224) | 4.39 | 0.000389 | 0.002715 |
GO:0045880 | positive regulation of smoothened signaling pathway | 1.34% (3/224) | 4.39 | 0.000389 | 0.002715 |
GO:0140513 | nuclear protein-containing complex | 8.93% (20/224) | 1.23 | 0.000391 | 0.002721 |
GO:0004540 | ribonuclease activity | 2.68% (6/224) | 2.67 | 0.000397 | 0.002756 |
GO:0097327 | response to antineoplastic agent | 1.34% (3/224) | 4.33 | 0.000438 | 0.003031 |
GO:1901699 | cellular response to nitrogen compound | 4.46% (10/224) | 1.88 | 0.00044 | 0.003036 |
GO:0042110 | T cell activation | 1.79% (4/224) | 3.49 | 0.000451 | 0.003107 |
GO:0048471 | perinuclear region of cytoplasm | 4.46% (10/224) | 1.87 | 0.000462 | 0.003171 |
GO:0007420 | brain development | 2.68% (6/224) | 2.62 | 0.000465 | 0.003185 |
GO:0005854 | nascent polypeptide-associated complex | 0.89% (2/224) | 5.86 | 0.000483 | 0.00328 |
GO:0009547 | plastid ribosome | 0.89% (2/224) | 5.86 | 0.000483 | 0.00328 |
GO:0043253 | chloroplast ribosome | 0.89% (2/224) | 5.86 | 0.000483 | 0.00328 |
GO:0009967 | positive regulation of signal transduction | 7.14% (16/224) | 1.39 | 0.000488 | 0.003306 |
GO:0005682 | U5 snRNP | 1.34% (3/224) | 4.28 | 0.000491 | 0.003314 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 4.02% (9/224) | 1.98 | 0.000534 | 0.003598 |
GO:0030695 | GTPase regulator activity | 2.68% (6/224) | 2.58 | 0.000542 | 0.003632 |
GO:0060589 | nucleoside-triphosphatase regulator activity | 2.68% (6/224) | 2.58 | 0.000542 | 0.003632 |
GO:0031929 | TOR signaling | 1.34% (3/224) | 4.22 | 0.000547 | 0.003656 |
GO:2001056 | positive regulation of cysteine-type endopeptidase activity | 1.79% (4/224) | 3.4 | 0.000573 | 0.003818 |
GO:0035770 | ribonucleoprotein granule | 4.02% (9/224) | 1.96 | 0.000594 | 0.003949 |
GO:1902555 | endoribonuclease complex | 1.34% (3/224) | 4.17 | 0.000608 | 0.004008 |
GO:0006448 | regulation of translational elongation | 1.34% (3/224) | 4.17 | 0.000608 | 0.004008 |
GO:2000765 | regulation of cytoplasmic translation | 1.34% (3/224) | 4.17 | 0.000608 | 0.004008 |
GO:0014074 | response to purine-containing compound | 2.68% (6/224) | 2.55 | 0.00061 | 0.004014 |
GO:0010950 | positive regulation of endopeptidase activity | 1.79% (4/224) | 3.36 | 0.000642 | 0.004198 |
GO:0005085 | guanyl-nucleotide exchange factor activity | 1.79% (4/224) | 3.36 | 0.000642 | 0.004198 |
GO:0005851 | eukaryotic translation initiation factor 2B complex | 0.89% (2/224) | 5.64 | 0.000674 | 0.004363 |
GO:1905348 | endonuclease complex | 1.34% (3/224) | 4.13 | 0.000672 | 0.004366 |
GO:0002366 | leukocyte activation involved in immune response | 1.34% (3/224) | 4.13 | 0.000672 | 0.004366 |
GO:0031327 | negative regulation of cellular biosynthetic process | 9.38% (21/224) | 1.13 | 0.000669 | 0.004369 |
GO:0071479 | cellular response to ionizing radiation | 1.79% (4/224) | 3.34 | 0.000678 | 0.004379 |
GO:0071549 | cellular response to dexamethasone stimulus | 1.34% (3/224) | 4.08 | 0.000741 | 0.004728 |
GO:1990928 | response to amino acid starvation | 1.34% (3/224) | 4.08 | 0.000741 | 0.004728 |
GO:0002263 | cell activation involved in immune response | 1.34% (3/224) | 4.08 | 0.000741 | 0.004728 |
GO:0031329 | regulation of cellular catabolic process | 5.8% (13/224) | 1.51 | 0.000739 | 0.004751 |
GO:0010558 | negative regulation of macromolecule biosynthetic process | 8.93% (20/224) | 1.16 | 0.000739 | 0.004758 |
GO:0010952 | positive regulation of peptidase activity | 1.79% (4/224) | 3.24 | 0.000883 | 0.0056 |
GO:0003899 | DNA-directed 5'-3' RNA polymerase activity | 1.79% (4/224) | 3.24 | 0.000883 | 0.0056 |
GO:0009890 | negative regulation of biosynthetic process | 9.38% (21/224) | 1.1 | 0.000916 | 0.005794 |
GO:0000054 | ribosomal subunit export from nucleus | 1.34% (3/224) | 3.94 | 0.000975 | 0.006137 |
GO:0033750 | ribosome localization | 1.34% (3/224) | 3.94 | 0.000975 | 0.006137 |
GO:0042177 | negative regulation of protein catabolic process | 2.23% (5/224) | 2.72 | 0.001013 | 0.006366 |
GO:0061515 | myeloid cell development | 1.34% (3/224) | 3.9 | 0.001061 | 0.006651 |
GO:0023056 | positive regulation of signaling | 7.14% (16/224) | 1.27 | 0.001103 | 0.006893 |
GO:1902229 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage | 1.34% (3/224) | 3.86 | 0.001153 | 0.00719 |
GO:0046677 | response to antibiotic | 1.79% (4/224) | 3.13 | 0.001181 | 0.00731 |
GO:0010332 | response to gamma radiation | 1.79% (4/224) | 3.13 | 0.001181 | 0.00731 |
GO:0008589 | regulation of smoothened signaling pathway | 1.79% (4/224) | 3.13 | 0.001181 | 0.00731 |
GO:1901701 | cellular response to oxygen-containing compound | 8.04% (18/224) | 1.17 | 0.001209 | 0.007463 |
GO:0006351 | DNA-templated transcription | 2.68% (6/224) | 2.35 | 0.001232 | 0.007585 |
GO:0000387 | spliceosomal snRNP assembly | 1.34% (3/224) | 3.82 | 0.00125 | 0.00764 |
GO:0071548 | response to dexamethasone | 1.34% (3/224) | 3.82 | 0.00125 | 0.00764 |
GO:0010647 | positive regulation of cell communication | 7.14% (16/224) | 1.26 | 0.001248 | 0.007669 |
GO:0051099 | positive regulation of binding | 2.23% (5/224) | 2.64 | 0.001317 | 0.008031 |
GO:0005689 | U12-type spliceosomal complex | 1.34% (3/224) | 3.78 | 0.001351 | 0.00822 |
GO:0019899 | enzyme binding | 10.71% (24/224) | 0.97 | 0.001383 | 0.008394 |
GO:0097659 | nucleic acid-templated transcription | 2.68% (6/224) | 2.32 | 0.001393 | 0.008432 |
GO:0034101 | erythrocyte homeostasis | 0.89% (2/224) | 5.13 | 0.001427 | 0.00854 |
GO:0031001 | response to brefeldin A | 0.89% (2/224) | 5.13 | 0.001427 | 0.00854 |
GO:1904748 | regulation of apoptotic process involved in development | 0.89% (2/224) | 5.13 | 0.001427 | 0.00854 |
GO:0000313 | organellar ribosome | 0.89% (2/224) | 5.13 | 0.001427 | 0.00854 |
GO:0034062 | 5'-3' RNA polymerase activity | 1.79% (4/224) | 3.05 | 0.001415 | 0.00855 |
GO:0071385 | cellular response to glucocorticoid stimulus | 1.34% (3/224) | 3.75 | 0.001457 | 0.008699 |
GO:0010033 | response to organic substance | 26.34% (59/224) | 0.53 | 0.001543 | 0.009186 |
GO:0071384 | cellular response to corticosteroid stimulus | 1.34% (3/224) | 3.71 | 0.001569 | 0.009321 |
GO:0097747 | RNA polymerase activity | 1.79% (4/224) | 3.0 | 0.001611 | 0.00955 |
GO:0071493 | cellular response to UV-B | 1.34% (3/224) | 3.67 | 0.001686 | 0.009944 |
GO:1901888 | regulation of cell junction assembly | 1.34% (3/224) | 3.67 | 0.001686 | 0.009944 |
GO:0099547 | regulation of translation at synapse, modulating synaptic transmission | 0.89% (2/224) | 4.99 | 0.001738 | 0.010158 |
GO:0140243 | regulation of translation at synapse | 0.89% (2/224) | 4.99 | 0.001738 | 0.010158 |
GO:0005126 | cytokine receptor binding | 0.89% (2/224) | 4.99 | 0.001738 | 0.010158 |
GO:0021782 | glial cell development | 0.89% (2/224) | 4.99 | 0.001738 | 0.010158 |
GO:0030098 | lymphocyte differentiation | 1.79% (4/224) | 2.97 | 0.001752 | 0.010215 |
GO:0007281 | germ cell development | 2.68% (6/224) | 2.25 | 0.001762 | 0.010251 |
GO:0016477 | cell migration | 2.68% (6/224) | 2.24 | 0.001803 | 0.010464 |
GO:0031960 | response to corticosteroid | 1.79% (4/224) | 2.96 | 0.001825 | 0.010569 |
GO:1990823 | response to leukemia inhibitory factor | 1.79% (4/224) | 2.94 | 0.001901 | 0.010955 |
GO:1990830 | cellular response to leukemia inhibitory factor | 1.79% (4/224) | 2.94 | 0.001901 | 0.010955 |
GO:0005686 | U2 snRNP | 1.34% (3/224) | 3.61 | 0.001935 | 0.011129 |
GO:0048468 | cell development | 5.36% (12/224) | 1.42 | 0.002015 | 0.01156 |
GO:0071004 | U2-type prespliceosome | 1.34% (3/224) | 3.57 | 0.002068 | 0.011813 |
GO:0071010 | prespliceosome | 1.34% (3/224) | 3.57 | 0.002068 | 0.011813 |
GO:0001054 | RNA polymerase I activity | 0.89% (2/224) | 4.86 | 0.002078 | 0.011841 |
GO:0017148 | negative regulation of translation | 2.68% (6/224) | 2.2 | 0.002108 | 0.011986 |
GO:0005525 | GTP binding | 3.12% (7/224) | 1.98 | 0.002145 | 0.012168 |
GO:0004518 | nuclease activity | 3.57% (8/224) | 1.82 | 0.002157 | 0.012208 |
GO:0071383 | cellular response to steroid hormone stimulus | 1.34% (3/224) | 3.54 | 0.002206 | 0.012434 |
GO:0060759 | regulation of response to cytokine stimulus | 1.34% (3/224) | 3.54 | 0.002206 | 0.012434 |
GO:0006399 | tRNA metabolic process | 3.57% (8/224) | 1.81 | 0.002224 | 0.01248 |
GO:0046907 | intracellular transport | 7.59% (17/224) | 1.13 | 0.002222 | 0.012492 |
GO:0005829 | cytosol | 21.43% (48/224) | 0.59 | 0.002277 | 0.012746 |
GO:0005681 | spliceosomal complex | 3.12% (7/224) | 1.96 | 0.002304 | 0.012871 |
GO:0140535 | intracellular protein-containing complex | 6.25% (14/224) | 1.27 | 0.002321 | 0.012933 |
GO:0010212 | response to ionizing radiation | 2.23% (5/224) | 2.45 | 0.002363 | 0.01314 |
GO:0000056 | ribosomal small subunit export from nucleus | 0.89% (2/224) | 4.75 | 0.002446 | 0.013573 |
GO:0043085 | positive regulation of catalytic activity | 4.02% (9/224) | 1.65 | 0.002567 | 0.014211 |
GO:0031333 | negative regulation of protein-containing complex assembly | 1.79% (4/224) | 2.82 | 0.002583 | 0.014271 |
GO:0015931 | nucleobase-containing compound transport | 3.12% (7/224) | 1.93 | 0.002606 | 0.014364 |
GO:0005783 | endoplasmic reticulum | 8.93% (20/224) | 1.0 | 0.002631 | 0.014468 |
GO:0051347 | positive regulation of transferase activity | 2.68% (6/224) | 2.13 | 0.002664 | 0.014588 |
GO:0034249 | negative regulation of cellular amide metabolic process | 2.68% (6/224) | 2.13 | 0.002664 | 0.014588 |
GO:0043433 | negative regulation of DNA-binding transcription factor activity | 1.79% (4/224) | 2.8 | 0.002679 | 0.014639 |
GO:1903131 | mononuclear cell differentiation | 1.79% (4/224) | 2.79 | 0.002777 | 0.01511 |
GO:0008266 | poly(U) RNA binding | 1.79% (4/224) | 2.79 | 0.002777 | 0.01511 |
GO:0060760 | positive regulation of response to cytokine stimulus | 0.89% (2/224) | 4.64 | 0.002843 | 0.015402 |
GO:0000466 | maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 0.89% (2/224) | 4.64 | 0.002843 | 0.015402 |
GO:0004521 | endoribonuclease activity | 1.79% (4/224) | 2.77 | 0.002878 | 0.015556 |
GO:0032092 | positive regulation of protein binding | 1.34% (3/224) | 3.36 | 0.003158 | 0.017032 |
GO:0008187 | poly-pyrimidine tract binding | 1.79% (4/224) | 2.73 | 0.003194 | 0.017194 |
GO:0016004 | phospholipase activator activity | 0.89% (2/224) | 4.54 | 0.003268 | 0.017442 |
GO:0060229 | lipase activator activity | 0.89% (2/224) | 4.54 | 0.003268 | 0.017442 |
GO:0007219 | Notch signaling pathway | 0.89% (2/224) | 4.54 | 0.003268 | 0.017442 |
GO:0019900 | kinase binding | 5.36% (12/224) | 1.33 | 0.003259 | 0.017507 |
GO:0042221 | response to chemical | 32.59% (73/224) | 0.42 | 0.003364 | 0.017916 |
GO:0004519 | endonuclease activity | 2.68% (6/224) | 2.05 | 0.003523 | 0.018643 |
GO:2000116 | regulation of cysteine-type endopeptidase activity | 1.79% (4/224) | 2.69 | 0.003534 | 0.018663 |
GO:0046540 | U4/U6 x U5 tri-snRNP complex | 1.34% (3/224) | 3.3 | 0.003522 | 0.01868 |
GO:0032561 | guanyl ribonucleotide binding | 3.12% (7/224) | 1.85 | 0.003521 | 0.01871 |
GO:0019001 | guanyl nucleotide binding | 3.12% (7/224) | 1.84 | 0.003694 | 0.019468 |
GO:0035167 | larval lymph gland hemopoiesis | 0.89% (2/224) | 4.45 | 0.003721 | 0.019487 |
GO:0097526 | spliceosomal tri-snRNP complex | 1.34% (3/224) | 3.28 | 0.003714 | 0.01949 |
GO:1901655 | cellular response to ketone | 1.34% (3/224) | 3.28 | 0.003714 | 0.01949 |
GO:0070925 | organelle assembly | 4.02% (9/224) | 1.55 | 0.003947 | 0.020626 |
GO:1901654 | response to ketone | 2.23% (5/224) | 2.26 | 0.0041 | 0.021382 |
GO:0072331 | signal transduction by p53 class mediator | 1.34% (3/224) | 3.22 | 0.004116 | 0.021421 |
GO:0048870 | cell motility | 2.68% (6/224) | 2.0 | 0.004174 | 0.02168 |
GO:0005697 | telomerase holoenzyme complex | 0.89% (2/224) | 4.36 | 0.004201 | 0.021687 |
GO:0000491 | small nucleolar ribonucleoprotein complex assembly | 0.89% (2/224) | 4.36 | 0.004201 | 0.021687 |
GO:0010243 | response to organonitrogen compound | 8.48% (19/224) | 0.97 | 0.004191 | 0.021723 |
GO:0048872 | homeostasis of number of cells | 1.79% (4/224) | 2.61 | 0.004285 | 0.022073 |
GO:0000243 | commitment complex | 0.89% (2/224) | 4.28 | 0.004709 | 0.024108 |
GO:0031125 | rRNA 3'-end processing | 0.89% (2/224) | 4.28 | 0.004709 | 0.024108 |
GO:0001056 | RNA polymerase III activity | 0.89% (2/224) | 4.28 | 0.004709 | 0.024108 |
GO:0043280 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic process | 1.34% (3/224) | 3.13 | 0.004997 | 0.025479 |
GO:0071007 | U2-type catalytic step 2 spliceosome | 1.34% (3/224) | 3.13 | 0.004997 | 0.025479 |
GO:0048856 | anatomical structure development | 27.23% (61/224) | 0.45 | 0.005137 | 0.026143 |
GO:0005736 | RNA polymerase I complex | 0.89% (2/224) | 4.2 | 0.005243 | 0.02652 |
GO:0051129 | negative regulation of cellular component organization | 3.57% (8/224) | 1.6 | 0.005238 | 0.026548 |
GO:0007369 | gastrulation | 1.34% (3/224) | 3.1 | 0.005233 | 0.026577 |
GO:0030099 | myeloid cell differentiation | 1.79% (4/224) | 2.53 | 0.005289 | 0.0267 |
GO:0000215 | tRNA 2'-phosphotransferase activity | 0.45% (1/224) | 7.45 | 0.005731 | 0.028416 |
GO:0000249 | C-22 sterol desaturase activity | 0.45% (1/224) | 7.45 | 0.005731 | 0.028416 |
GO:0032057 | negative regulation of translational initiation in response to stress | 0.45% (1/224) | 7.45 | 0.005731 | 0.028416 |
GO:0044207 | translation initiation ternary complex | 0.45% (1/224) | 7.45 | 0.005731 | 0.028416 |
GO:0097451 | glial limiting end-foot | 0.45% (1/224) | 7.45 | 0.005731 | 0.028416 |
GO:0005172 | vascular endothelial growth factor receptor binding | 0.45% (1/224) | 7.45 | 0.005731 | 0.028416 |
GO:0043184 | vascular endothelial growth factor receptor 2 binding | 0.45% (1/224) | 7.45 | 0.005731 | 0.028416 |
GO:1902605 | heterotrimeric G-protein complex assembly | 0.45% (1/224) | 7.45 | 0.005731 | 0.028416 |
GO:0060265 | positive regulation of respiratory burst involved in inflammatory response | 0.45% (1/224) | 7.45 | 0.005731 | 0.028416 |
GO:0060041 | retina development in camera-type eye | 0.89% (2/224) | 4.13 | 0.005803 | 0.028442 |
GO:0042797 | tRNA transcription by RNA polymerase III | 0.89% (2/224) | 4.13 | 0.005803 | 0.028442 |
GO:0007000 | nucleolus organization | 0.89% (2/224) | 4.13 | 0.005803 | 0.028442 |
GO:0035166 | post-embryonic hemopoiesis | 0.89% (2/224) | 4.13 | 0.005803 | 0.028442 |
GO:0030239 | myofibril assembly | 0.89% (2/224) | 4.13 | 0.005803 | 0.028442 |
GO:0002521 | leukocyte differentiation | 1.79% (4/224) | 2.49 | 0.005764 | 0.028524 |
GO:0065008 | regulation of biological quality | 17.41% (39/224) | 0.59 | 0.005861 | 0.028667 |
GO:2000113 | negative regulation of cellular macromolecule biosynthetic process | 2.68% (6/224) | 1.89 | 0.005935 | 0.028974 |
GO:0032502 | developmental process | 34.82% (78/224) | 0.37 | 0.006047 | 0.029464 |
GO:0009894 | regulation of catabolic process | 5.8% (13/224) | 1.16 | 0.006107 | 0.029699 |
GO:0034504 | protein localization to nucleus | 2.23% (5/224) | 2.12 | 0.006208 | 0.030132 |
GO:0009304 | tRNA transcription | 0.89% (2/224) | 4.05 | 0.00639 | 0.030838 |
GO:0004407 | histone deacetylase activity | 0.89% (2/224) | 4.05 | 0.00639 | 0.030838 |
GO:0033558 | protein lysine deacetylase activity | 0.89% (2/224) | 4.05 | 0.00639 | 0.030838 |
GO:0010557 | positive regulation of macromolecule biosynthetic process | 9.82% (22/224) | 0.83 | 0.006728 | 0.032404 |
GO:0046649 | lymphocyte activation | 1.79% (4/224) | 2.42 | 0.006796 | 0.032672 |
GO:0051059 | NF-kappaB binding | 0.89% (2/224) | 3.99 | 0.007003 | 0.033537 |
GO:1902165 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | 0.89% (2/224) | 3.99 | 0.007003 | 0.033537 |
GO:0005844 | polysome | 1.34% (3/224) | 2.94 | 0.007077 | 0.033828 |
GO:0034644 | cellular response to UV | 1.79% (4/224) | 2.38 | 0.007549 | 0.036013 |
GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | 0.89% (2/224) | 3.92 | 0.007641 | 0.036317 |
GO:1905097 | regulation of guanyl-nucleotide exchange factor activity | 0.89% (2/224) | 3.92 | 0.007641 | 0.036317 |
GO:0071705 | nitrogen compound transport | 8.93% (20/224) | 0.85 | 0.008226 | 0.039025 |
GO:0010662 | regulation of striated muscle cell apoptotic process | 0.89% (2/224) | 3.86 | 0.008305 | 0.039248 |
GO:0010664 | negative regulation of striated muscle cell apoptotic process | 0.89% (2/224) | 3.86 | 0.008305 | 0.039248 |
GO:0032434 | regulation of proteasomal ubiquitin-dependent protein catabolic process | 2.23% (5/224) | 2.01 | 0.008338 | 0.039334 |
GO:0003697 | single-stranded DNA binding | 2.23% (5/224) | 2.01 | 0.008496 | 0.040003 |
GO:0006886 | intracellular protein transport | 4.91% (11/224) | 1.22 | 0.008527 | 0.040072 |
GO:0008408 | 3'-5' exonuclease activity | 1.34% (3/224) | 2.82 | 0.008928 | 0.041879 |
GO:0005791 | rough endoplasmic reticulum | 0.89% (2/224) | 3.8 | 0.008993 | 0.04195 |
GO:0034198 | cellular response to amino acid starvation | 0.89% (2/224) | 3.8 | 0.008993 | 0.04195 |
GO:0051098 | regulation of binding | 2.68% (6/224) | 1.77 | 0.008965 | 0.041977 |
GO:0005743 | mitochondrial inner membrane | 1.79% (4/224) | 2.26 | 0.010128 | 0.04716 |
GO:0051649 | establishment of localization in cell | 7.59% (17/224) | 0.91 | 0.010175 | 0.047291 |
GO:0006914 | autophagy | 2.23% (5/224) | 1.94 | 0.010371 | 0.048025 |
GO:0000003 | reproduction | 1.79% (4/224) | 2.25 | 0.010366 | 0.048089 |
GO:0001824 | blastocyst development | 0.89% (2/224) | 3.69 | 0.010443 | 0.048179 |
GO:0010656 | negative regulation of muscle cell apoptotic process | 0.89% (2/224) | 3.69 | 0.010443 | 0.048179 |
GO:0097163 | sulfur carrier activity | 0.45% (1/224) | 6.45 | 0.011429 | 0.049894 |
GO:0071209 | U7 snRNA binding | 0.45% (1/224) | 6.45 | 0.011429 | 0.049894 |
GO:0061711 | N(6)-L-threonylcarbamoyladenine synthase activity | 0.45% (1/224) | 6.45 | 0.011429 | 0.049894 |
GO:0005133 | interferon-gamma receptor binding | 0.45% (1/224) | 6.45 | 0.011429 | 0.049894 |
GO:0060330 | regulation of response to interferon-gamma | 0.45% (1/224) | 6.45 | 0.011429 | 0.049894 |
GO:0060331 | negative regulation of response to interferon-gamma | 0.45% (1/224) | 6.45 | 0.011429 | 0.049894 |
GO:0060334 | regulation of interferon-gamma-mediated signaling pathway | 0.45% (1/224) | 6.45 | 0.011429 | 0.049894 |
GO:0060336 | negative regulation of interferon-gamma-mediated signaling pathway | 0.45% (1/224) | 6.45 | 0.011429 | 0.049894 |
GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator | 0.45% (1/224) | 6.45 | 0.011429 | 0.049894 |
GO:1902162 | regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator | 0.45% (1/224) | 6.45 | 0.011429 | 0.049894 |
GO:1902164 | positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator | 0.45% (1/224) | 6.45 | 0.011429 | 0.049894 |
GO:1902167 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | 0.45% (1/224) | 6.45 | 0.011429 | 0.049894 |
GO:1904803 | regulation of translation involved in cellular response to UV | 0.45% (1/224) | 6.45 | 0.011429 | 0.049894 |
GO:0036499 | PERK-mediated unfolded protein response | 0.45% (1/224) | 6.45 | 0.011429 | 0.049894 |
GO:1990737 | response to manganese-induced endoplasmic reticulum stress | 0.45% (1/224) | 6.45 | 0.011429 | 0.049894 |
GO:0031416 | NatB complex | 0.45% (1/224) | 6.45 | 0.011429 | 0.049894 |
GO:0038128 | ERBB2 signaling pathway | 0.45% (1/224) | 6.45 | 0.011429 | 0.049894 |
GO:0035517 | PR-DUB complex | 0.45% (1/224) | 6.45 | 0.011429 | 0.049894 |
GO:0061519 | macrophage homeostasis | 0.45% (1/224) | 6.45 | 0.011429 | 0.049894 |
GO:0097356 | perinucleolar compartment | 0.45% (1/224) | 6.45 | 0.011429 | 0.049894 |
GO:0002548 | monocyte chemotaxis | 0.45% (1/224) | 6.45 | 0.011429 | 0.049894 |
GO:0060264 | regulation of respiratory burst involved in inflammatory response | 0.45% (1/224) | 6.45 | 0.011429 | 0.049894 |
GO:0060266 | negative regulation of respiratory burst involved in inflammatory response | 0.45% (1/224) | 6.45 | 0.011429 | 0.049894 |
GO:0060268 | negative regulation of respiratory burst | 0.45% (1/224) | 6.45 | 0.011429 | 0.049894 |
GO:0000493 | box H/ACA snoRNP assembly | 0.45% (1/224) | 6.45 | 0.011429 | 0.049894 |